Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Entrada Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −5 vs. Q2 2022
- Shares held
- 24.5M
- −261.7K (−1.1%) vs. Q2 2022
- Total value
- $386.4M
- +$84.5M (+28.0%) vs. Q2 2022
- New holders
- 4
- 14 more added
- Sold out
- 9
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $214.4M |
| Q1 2026 | 119 | $321.4M |
| Q4 2025 | 113 | $251.0M |
| Q3 2025 | 116 | $164.8M |
| Q2 2025 | 107 | $198.8M |
| Q1 2025 | 110 | $274.5M |
| Q4 2024 | 102 | $529.8M |
| Q3 2024 | 97 | $481.1M |
| Q2 2024 | 84 | $423.1M |
| Q1 2024 | 77 | $368.8M |
| Q4 2023 | 62 | $396.6M |
| Q3 2023 | 55 | $411.4M |
| Q2 2023 | 56 | $389.9M |
| Q1 2023 | 53 | $361.0M |
| Q4 2022 | 47 | $334.2M |
| Q3 2022 | 33 | $386.4M |
| Q2 2022 | 38 | $301.8M |
| Q1 2022 | 48 | $242.8M |
| Q4 2021 | 46 | $433.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 4,865,819 | $76.7M | 0.50% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,425,784 | $69.8M | 26.57% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 4,408,379 | $69.5M | 13.31% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,972,050 | $46.8M | 0.01% | +534,552+21.9% | Added |
| Redmile Group, LLC | 1,954,419 | $30.8M | 1.19% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,007,246 | $15.9M | 0.00% | −528,637−34.4% | Reduced |
| Vanguard Group Inc | 870,147 | $13.7M | 0.00% | +107,783+14.1% | Added |
| StepStone Group LP | 761,277 | $12.0M | 1.71% | +126,318+19.9% | Added |
| TCG Crossover Management, LLC | 642,189 | $10.1M | 3.04% | −21,505−3.2% | Reduced |
| 72 Investment Holdings, LLC | 509,023 | $8.02M | 6.35% | 00.0% | Unchanged |
| FMR LLC | 503,907 | $7.94M | 0.00% | −441,001−46.7% | Reduced |
| Goldman Sachs Group Inc | 449,993 | $7.09M | 0.00% | +4,307+1.0% | Added |
| Laurion Capital Management LP | 199,066 | $3.14M | 0.09% | +70,000+54.2% | Added |
| Geode Capital Management, LLC | 167,118 | $2.63M | 0.00% | +65,347+64.2% | Added |
| BlackRock Inc. | 147,593 | $2.33M | 0.00% | +82,594+127.1% | Added |
| Nan Fung Group Holdings Ltd | 141,593 | $2.23M | 1.42% | −31,989−18.4% | Reduced |
| Moore Capital Management, LP | 105,000 | $1.66M | 0.05% | 00.0% | Unchanged |
| Invesco Ltd. | 95,209 | $1.50M | 0.00% | +95,209 | New |
| Charles Schwab Investment Management Inc | 87,859 | $1.39M | 0.00% | +45,077+105.4% | Added |
| TD Asset Management Inc | 59,496 | $925.0K | 0.00% | +1,821+3.2% | Added |
| Manufacturers Life Insurance Company, The | 41,175 | $640.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 33,294 | $525.0K | 0.00% | +3,100+10.3% | Added |
| Northern Trust Corp | 29,997 | $473.0K | 0.00% | +13,669+83.7% | Added |
| Fred Alger Management, LLC | 17,955 | $283.0K | 0.00% | +17,955 | New |
| Morgan Stanley | 10,530 | $166.0K | 0.00% | −10,655−50.3% | Reduced |
| Bank of America Corp | 3,966 | $63.0K | 0.00% | −9,025−69.5% | Reduced |
| Tower Research Capital LLC (TRC) | 2,508 | $40.0K | 0.00% | +2,508 | New |
| Citigroup Inc | 1,583 | $25.0K | 0.00% | +1,489+1,584.0% | Added |
| Barclays PLC | 1,215 | $19.0K | 0.00% | +1,179+3,275.0% | Added |
| Cubist Systematic Strategies, LLC | 1,005 | $16.0K | 0.00% | −869−46.4% | Reduced |
| Advisor Group Holdings, Inc. | 300 | $5.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 198 | $3.12K | 0.00% | +198 | New |
| Wells Fargo & Company | 165 | $3.00K | 0.00% | +52+46.0% | Added |
| CHI Advisors LLC | 0 | $0 | 0.00% | −163,496−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −106,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −76,498−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −18,807−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,947−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −597−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −6−100.0% | Sold out |